Table 1.
Functional and anatomical status after vitrectomy with silicone oil infusion for proliferative diabetic vitrectomy. Patients 7, 16, and 23 had repeat vitrectomy and silicone oil infusion with final retinal reattachment
| Case No | Age/sex/ race/eye | Diagnosis | Length of follow up (months) | Vision (preop/final) | IOP (preop/postop) | Rubeosis (preop/postop) | NVG (preop/postop) | Anatomical outcome |
| 1 | 58/F/H/RE | PDR, TRRD, RI, hypotony | 1 | LP/LP | 6 mm/5 mm | RI/no change | None | Retina flat SO present |
| 2 | 59/F/AA/RE | PDR, TRD, VH | 5 | HM/CF 1 ft | 19 mm/22 mm | None | None | Retina flat SO present |
| 3 | 70/M/AA/LE | PDR, TRD, recurrent VH | 4 | CF 2ft/ 5/200 |
22 mm/15 mm | None/RI | None | Retina flat SO present |
| 4 | 21/F/AA/RE | PDR, RI, NVG, TRD, subluxed lens | 12 | CF 2ft/ 5/160 | 16 mm/7 mm | RI/regressed | NVG/resolved | Retina flat SO present |
| 5 | 21/F/AA/LE | PDR, RI NVG, TRD, FS | 1 | LP/LP | 14 mm/20 mm | RI/no change | NVG/IOP is normal | Retina flat SO present |
| 6 | 60/M/AA/RE | PDR, TRD, RI, FS | 4 | LP/10/200 | 12 mm/9 mm | RI/regressed | None | Retina flat SO present |
| 7 | 52/M/H/RE | PDR, TRD, VH, FS | 12 | LP/HM | 9 mm/2 mm | None | None | Recurrent RD SO present |
| 8 | 44/M/H/RE | PDR, TRD, VH | 2 | CF 1 ft/ 20/80 |
10 mm/15 mm | None | None | Retina flat SO removed |
| 9 | 36/M/AA/RE | PDR, TRD, VH | 1 | CF 2 ft/ 5/200 |
17 mm/21 mm | None | None | Retina flat SO present |
| 10 | 36/M/AA/LE | PDR, TRD, VH | 3 | HM/LP | 15 mm/14 mm | None | None | Retina flat SO present |
| 11 | 49/F/AA/RE | PDR, TRD, VH, CT | 1 | CF 1 ft/HM | 11 mm/32 mm | None | None | RD |
| 12 | 82/F/AA/RE | PDR, TRD | 3 | LP/NLP | 14 mm/8 mm | None | None | Retina flat |
| 13 | 52/M/AA/RE | PDR, TRD, RI | 9 | HM/LP | 12 mm/2 mm | RI/regressed | None | RD SO present |
| 14 | 75/F/AA/RE | PDR, TRD, VH | 18 | LP/HM | 9 mm/3 mm | None | None | RD (peripheral) SO present |
| 15 | 52/F/H/LE | PDR, TRD, CT, RI HYP | 1 | HM/CF 1 ft | 12 mm/12 mm | RI/no change | None | Retina flat SO present |
| 16 | 68/M/AA/LE | PDR, TRRD | 3 | CF 2 ft/HM | 19 mm/15 mm | None | None | TRD |
| 17 | 58/M/AA/RE | PDR, TRD, VH | 1 | CF 1 ft/LP | 16 mm/15 mm | None | None | Retina flat SO present |
| 18 | 29/F/H/LE | PDR, TRD, VH | 6 | HM/LP | 13 mm/12 mm | None | None | RD SO present |
| 19 | 59/F/AA/RE | PDR, TRD, ERM, VH | 25 | 5/200/ CF 2 ft |
12 mm/27 mm | None | None | Retina flat SO present |
| 20 | 58/M/AA/RE | PDR, TRD, FS | 8 | LP/CF 2 ft | 13 mm/16 mm | None | None | Retina flat SO removed |
| 21 | 74/M/AA/RE | PDR, TRD, CSME | 2 | HM/HM | 10 mm/25 mm | None | None | Retina flat SO removed |
| 22 | 56/M/H/LE | PDR, TRD, VH, RI, NVG | 1 | LP/NLP | 32 mm/5 mm | RI/no change | NVG/IOP is normal | Retina flat SO present |
| 23 | 58/M/H/LE | PDR, TRD, VH | 2 | HM/LP | 14 mm/22 mm | None/RI | None | RD SO present |
PDR = proliferative diabetic retinopathy; TRRD = tractional rhegmatogenous retinal detachment; RI = rubeosis iridis; SO = silicone oil; TRD = tractional retinal detachment; VH = vitreous haemorrhage; NVG = neovascular glaucoma; FS = fibrinoid syndrome; RD = retinal detachment; CT = cataract; HYP = hyphaema; ERM = epiretinal membrane.